Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.162
+0.038 (3.38%)
At close: Apr 2, 2026
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €108.91 million as of April 2, 2026. Its market cap has decreased by -29.46% in one year.
Market Cap
108.91M
Enterprise Value
97.17M
Revenue
9.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.16
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 108.91M, an increase of 13,648.94%. That is a compound annual growth rate of 28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 108.91M | -26.25% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 225.40M |
| Sensorion | 215.15M |
| Transgene | 202.63M |
| ABIONYX Pharma | 130.35M |
| MaaT Pharma | 107.63M |
| Adocia | 90.91M |
| OSE Immunotherapeutics | 73.76M |
| Valerio Therapeutics Société anonyme | 59.88M |